New York § 6830 Standardized patient-centered data elements

New York Statutes

§ 6830 — Standardized patient-centered data elements

New York § 6830

Law EDNEducation

Title 8The Professions

Art. 137Pharmacy

This text of New York § 6830 (Standardized patient-centered data elements) is published on Counsel Stack Legal Research, covering New York primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook

N.Y. Education § 6830 (2026).

Text

§ 6830. Standardized patient-centered data elements.

1.The\ncommissioner shall develop rules and regulations requiring standardized\npatient-centered data elements consistent with existing technology and\nequipment to be used on all prescription medicine dispensed to patients\nin this state.\n 2. When developing the requirements for patient-centered data elements\non prescription drug labels, the commissioner shall consider:\n (a) medical literacy research that identifies factors that improve\nunderstandability of labels and promotes increased compliance with a\ndrug's intended use;\n (b) factors that improve the clarity of directions for use;\n (c) font types and sizes;\n (d) inclusion of only patient-centered information; and\n (e) the needs of special populations.\nTo ensure pu

Free access — add to your briefcase to read the full text and ask questions with AI

§ 6830. Standardized patient-centered data elements. 1. The\ncommissioner shall develop rules and regulations requiring standardized\npatient-centered data elements consistent with existing technology and\nequipment to be used on all prescription medicine dispensed to patients\nin this state.\n 2. When developing the requirements for patient-centered data elements\non prescription drug labels, the commissioner shall consider:\n (a) medical literacy research that identifies factors that improve\nunderstandability of labels and promotes increased compliance with a\ndrug's intended use;\n (b) factors that improve the clarity of directions for use;\n (c) font types and sizes;\n (d) inclusion of only patient-centered information; and\n (e) the needs of special populations.\nTo ensure public input, the commissioner shall solicit input from the\nstate board of pharmacy and the state board of medicine, consumer\ngroups, advocates for special populations, pharmacists, physicians,\nother health care professionals authorized to prescribe, and other\ninterested parties.\n